Summary
Shanghai MicroPort Endovascular MedTech Group Co Ltd (MicroPort Endovascular MedTech), a subsidiary of MicroPort Scientific Corp, specializes in the research, development, manufacturing, sales, and services of aortic and peripheral vascular intervention devices. The company's product portfolio includes thoracic and abdominal aortic stent grafts, stent-grafts in surgical operations, drug-coated balloon dilatation catheters, peripheral vascular stents, and balloon dilatation catheters. The company operates under the brands Endovastec, Castor, Hercules, Minos, Aegis, CRONUS, Fontus and Talos. MicroPort Endovascular MedTech products are used in hospitals for the treatment of peripheral venous diseases, peripheral arterial diseases, and tumors. The company distributes its products through a network of hospitals in both domestic and international markets in Europe, Latin America, and Southeast Asia. MicroPort Endovascular MedTech is headquartered in Shanghai, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook